Abstract
Previous work in our laboratory has shown that human skin fibroblasts (HSF) and human lymphocytes carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase (G6PD) exhibit a great decrease in hexose monophosphate shunt and in NADP /NADPH ratio1,2. G6PD deficiency protects in vitro growing HSF and lymphocytes from benzo(a)pyrene (BaP) toxicity. G6PD-deficient HSF give rise in soft agar, after incubation with BaP, to a lower number of colonies than normal HSF1. Aryl hydrocarbon hydroxylase (AHH) activities are lower in G6PD-deficient cells, when tested in the absence of exogenous NADPH2. G6PD-deficient cells, incubated in vitro with BaP, produce low amounts of organic- and water-soluble BaP metabolites and show a decreased ability to form BaP-7,8-diol-9,10-epoxide and BaP-DNA adducts3,4.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
F. Feo, L. Pirisi, R. Pascale, L. Daino, S. Frassetto and R. Garcea, Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on the benzo(a)pyrene toxicity and transforming activity for in vitro cultured human skin fibroblasts, Cancer Res. 38:3419 (1984).
F. Feo, L. Pirisi, R. Pascale, L. Daino, S. Frassetto, S. Zanetti and R. Garcea, Modulatory mechanisms of chemical carcinogenesis: the role of the NADPH pool in benzo(a)pyrene activation, Toxicol. Pathol. 12:262 (1984).
L. Pirisi, R. Garcea, R. Pascale, M. E. Ruggiu and F. Feo, Control of glucose-6-phosphate dehydrogenase deficiency on the formation of mutagenic and carcinogenic metabolites derived from benzo(a)pyrene, Toxicol. Pathol. 15:115 (1987).
F. Feo, M. E. Ruggiu, L. Lenzerini, R. Garcea, L. Daino, S. Frassetto, V. Addis, L. Gaspa and R. Pascale, Benzo(a)pyrene metabolism by lymphocytes from normal individuals and individuals carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase, Int. J. Cancer 39:560 (1987).
K. Rudo, S. Ellis, B. J. Bryant, K. Lawrence, G. Curtis, H. Garland and S. Nesnow, Quantitative analysis of the metabolism of benzo(a)pyrene by transformable C3H10T1/2CL8 mouse embryo fibroblasts, Teratog. Carcinog. Mutagen. 6:307 (1986).
L. A. Reinke, F. C. Kauffman, S. A. Belinsky and R. G. Thurman, Interactions between ethanol metabolism and mixed function oxidation in perfused rat liver: inhibition of p-nitroanisole O-demethylation, J. Pharmacol. Exp. Ther. 213:70 (1980).
L. A. Reinke, P. McManus, F. C. Kauffman and R. G. Thurman, Benzo(a)-pyrene phenol production by perfused rat liver and its inhibition by ethanol, Cancer Res. 4:1681 (1982).
I. J. Sadowski, J. A. Wright and L. G. Israels, A permeabilized cell system for studying regulation of aryl hydrocarbon hydroxylase: NADPH as rate limiting factor in benzo(a)pyrene metabolism, Int. J. Biochem. 17:1025 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pascale, R. et al. (1988). Relationships between NADPH Content and Benzo(a)pyrene Metabolism in Normal and Glucose-6-Phosphate Dehydrogenase-Deficient Human Fibroblasts. In: Feo, F., Pani, P., Columbano, A., Garcea, R. (eds) Chemical Carcinogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9640-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9640-7_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9642-1
Online ISBN: 978-1-4757-9640-7
eBook Packages: Springer Book Archive